Laura Mazilu

University C2 Street
Constanta, CT 900527, Romania

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints.

Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints.

Journal: Cancers
Published: April 07, 2026

Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Journal: Current oncology (Toronto, Ont.)
Published: December 14, 2025

Career challenges of young oncologists in Romania: a nationwide survey.

Career challenges of young oncologists in Romania: a nationwide survey.

Journal: BMC medical education
Published: December 02, 2025

Advances in the management of neuroendocrine tumours: Evidence from a systematic review.

Advances in the management of neuroendocrine tumours: Evidence from a systematic review.

Journal: Biomedical reports
Published: October 29, 2025

Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Oncology
Published: April 09, 2025

Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor Microenvironment.

Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor Microenvironment.

Journal: Biomedicines
Published: January 31, 2025

An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology.

An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2024

Lung Cancer in Romania.

Lung Cancer in Romania.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 02, 2024

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 03, 2024

Digital technology for health shows disparities in cancer prevention between digital health technology users and the general population in Romania.

Digital technology for health shows disparities in cancer prevention between digital health technology users and the general population in Romania.

Journal: Frontiers in oncology
Published: March 15, 2023

Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis.

Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis.

Journal: Biomedicines
Published: June 02, 2022

Role of glutathione-S-transferase gene P1 in the diagnosis of prostate cancer in patients with 'grey level' prostate-specific antigen values.

Role of glutathione-S-transferase gene P1 in the diagnosis of prostate cancer in patients with 'grey level' prostate-specific antigen values.

Journal: Experimental and therapeutic medicine
Published: April 05, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026